Avid Bioservices Inc (CDMO)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Steven W. King
Employees:
211
2642 MICHELLE DRIVE, SUITE 200, TUSTIN, CA 92780
714.508.6100

Peregrine Pharmaceuticals, Inc. is a biopharmaceutical company that engages in the provision of monoclonal antibody therapeutics. It operates through Peregrine and Avid segments. The Peregrine segment refers to research and development of monoclonal antibodies for the treatment and diagnosis of cancer. The Avid segment provides contract management services for peregrine and third-party customers on a fee-for-services basis. The company was founded on June 3, 1981 and is headquartered in Tustin, CA.

Data derived from most recent annual or quarterly report
Market Cap 776.744 Million Shares Outstanding61.744 Million Avg 30-day Volume 773.735 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS0.01
Price to Revenue6.754 Debt to Equity3.1099 EBITDA347 Thousand
Price to Book Value10.5676 Operating Margin-4.0779000000000005 Enterprise Value450.817 Million
Current Ratio3.175 EPS Growth0 Quick Ratio2.815
1 Yr BETA 1.5221 52-week High/Low 34.51 / 11.3 Profit Margin-3.6827
Operating Cash Flow Growth191.0355 Altman Z-Score-0.7741 Free Cash Flow to Firm -5.01 Million
Earnings Report2022-06-28
View SEC Filings from CDMO instead.

View recent insider trading info

Funds Holding CDMO (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding CDMO BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

9 Thousand total shares from 4 transactions

Exercise Derivative Conversion (M)

17.8 Thousand total shares from 5 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

HANCOCK RICHARD B

  • Director
70,850 2022-05-07 9

HART DANIEL R CHIEF FINANCIAL OFFICER

  • Officer
104,328 2022-04-09 7

ZIEBELL MARK R V. P., GENERAL COUNSEL

  • Officer
57,990 2022-04-09 9

GREEN NICHOLAS STEWART PRESIDENT & CEO

  • Officer
  • Director
244,100 2022-04-09 7

CARLEONE JOSEPH

  • Director
73,956 2021-12-14 1

SARGEN GREGORY

  • Director
4,632 2021-12-14 1

MACKEY CATHERINE J

  • Director
4,632 2021-12-14 1

THOMA JEANNE

  • Director
7,706 2021-12-14 2

ALEGRIA ESTHER M.

  • Director
6,699 2021-12-14 3

BAMFORTH MARK R

  • Director
126,000 2021-03-17 0

WALSH PATRICK D

  • Director
0 2020-12-14 0

LIAS ROGER J. PRESIDENT & CEO

  • Officer
  • Director
2,289 2019-04-30 0

MCCOMB JOEL

  • Director
0 2018-12-14 0

HEDBERG STEPHEN MICHAEL PRINCIPAL FIN. & ACCT. OFFICER

  • Officer
9,687 2018-07-11 0

KINJERSKI TRACY VP, BUSINESS OPERATIONS

  • Officer
0 2018-01-18 0

KING STEVEN W PRESIDENT & CEO

  • Officer
  • Director
34,646 2017-10-31 0

SHAN JOSEPH VP, CLINICAL AND REG AFFAIRS

  • Officer
16,187 2017-10-31 0

EASTERN CAPITAL LTD

PORTFOLIO SERVICES LTD.

DART KENNETH BRYAN

  • 10% Owner
No longer subject to file 2017-09-11 0

POHL DAVID

  • Director
0 2017-08-25 0

JOHNSON CARLTON M

  • Director
0 2017-08-25 0

SWARTZ ERIC S

  • Director
0 2017-08-25 0

LYTLE PAUL J CHIEF FINANCIAL OFFICER

  • Officer
184,038 2017-04-28 0

FUSSEY SHELLEY PM V.P., INTELLECTUAL PROPERTY

  • Officer
135,908 2016-10-31 0

MASTEN JEFFREY L. V.P. QUALITY

  • Officer
0 2013-05-06 0

KING F DAVID V.P., BUSINESS DEVELOPMENT

  • Officer
No longer subject to file 2009-10-21 0

WALTZ THOMAS A

  • Director
2,500 2008-01-11 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

HANCOCK RICHARD B - Director

2022-05-10 20:07:33 -0400 2022-05-07 M 4,988 d 30,662 direct

HANCOCK RICHARD B - Director

2022-05-10 20:07:33 -0400 2022-05-07 M 4,988 a 40,188 direct 2.8229 -0.5133 7.1001 3 -0.5133 6

GREEN NICHOLAS STEWART - Director - Officer PRESIDENT & CEO

2022-04-12 19:50:50 -0400 2022-04-11 S 2,939 $18.56 d 28,103 direct -2.0856 -7.4866 0.0 1 -7.4866 6

HART DANIEL R - Officer CHIEF FINANCIAL OFFICER

2022-04-12 19:54:28 -0400 2022-04-11 S 726 $18.56 d 28,770 direct -2.0856 -7.4866 0.0 1 -7.4866 6

ZIEBELL MARK R - Officer V. P., GENERAL COUNSEL

2022-04-12 19:58:03 -0400 2022-04-11 S 368 $18.56 d 8,103 direct -2.0856 -7.4866 0.0 1 -7.4866 6

ZIEBELL MARK R - Officer V. P., GENERAL COUNSEL

2022-04-12 19:58:03 -0400 2022-04-09 M 696 a 8,471 direct -2.0856 -7.4866 0.0 1 -7.4866 6

GREEN NICHOLAS STEWART - Director - Officer PRESIDENT & CEO

2022-04-12 19:50:50 -0400 2022-04-09 M 5,574 d 184,955 direct

HART DANIEL R - Officer CHIEF FINANCIAL OFFICER

2022-04-12 19:54:28 -0400 2022-04-09 M 1,520 d 46,062 direct

ZIEBELL MARK R - Officer V. P., GENERAL COUNSEL

2022-04-12 19:58:03 -0400 2022-04-09 M 696 d 41,416 direct

GREEN NICHOLAS STEWART - Director - Officer PRESIDENT & CEO

2022-04-12 19:50:50 -0400 2022-04-09 M 5,574 a 31,042 direct -2.0856 -7.4866 0.0 1 -7.4866 6

HART DANIEL R - Officer CHIEF FINANCIAL OFFICER

2022-04-12 19:54:28 -0400 2022-04-09 M 1,520 a 29,496 direct -2.0856 -7.4866 0.0 1 -7.4866 6

HANCOCK RICHARD B - Director

2022-04-05 19:43:31 -0400 2022-04-01 M 5,000 $4.67 a 40,200 direct yes -1.3584 -2.2989 -34.744 0.0 1 -39.2372 30

HANCOCK RICHARD B - Director

2022-04-05 19:43:31 -0400 2022-04-01 M 5,000 d 228,887 direct yes

HANCOCK RICHARD B - Director

2022-04-05 19:43:31 -0400 2022-04-01 S 5,000 $21.21 d 35,200 direct yes -1.3584 -2.2989 -34.744 0.0 1 -39.2372 30

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
AVID BIOSERVICES INC CDMO 2022-05-25 22:15:03 UTC 0.5657 0.2543 1000000
AVID BIOSERVICES INC CDMO 2022-05-25 21:45:03 UTC 0.5657 0.2543 1000000
AVID BIOSERVICES INC CDMO 2022-05-25 21:15:03 UTC 0.5657 0.2543 1000000
AVID BIOSERVICES INC CDMO 2022-05-25 20:45:03 UTC 0.57 0.25 1000000
AVID BIOSERVICES INC CDMO 2022-05-25 20:15:10 UTC 0.57 0.25 1000000
AVID BIOSERVICES INC CDMO 2022-05-25 19:45:03 UTC 0.57 0.25 1000000
AVID BIOSERVICES INC CDMO 2022-05-25 19:15:04 UTC 0.57 0.25 1000000
AVID BIOSERVICES INC CDMO 2022-05-25 18:45:03 UTC 0.57 0.25 1000000
AVID BIOSERVICES INC CDMO 2022-05-25 18:15:03 UTC 0.57 0.25 1000000
AVID BIOSERVICES INC CDMO 2022-05-25 17:45:03 UTC 0.57 0.25 1000000
AVID BIOSERVICES INC CDMO 2022-05-25 17:15:03 UTC 0.57 0.25 1000000
AVID BIOSERVICES INC CDMO 2022-05-25 16:45:03 UTC 0.57 0.25 1000000
AVID BIOSERVICES INC CDMO 2022-05-25 16:15:03 UTC 0.57 0.25 1000000
AVID BIOSERVICES INC CDMO 2022-05-25 15:45:04 UTC 0.57 0.25 1000000
AVID BIOSERVICES INC CDMO 2022-05-25 15:15:03 UTC 0.57 0.25 1000000
AVID BIOSERVICES INC CDMO 2022-05-25 14:45:03 UTC 0.57 0.25 1000000
AVID BIOSERVICES INC CDMO 2022-05-25 14:15:04 UTC 0.57 0.25 1000000
AVID BIOSERVICES INC CDMO 2022-05-25 13:45:03 UTC 0.57 0.25 1000000
AVID BIOSERVICES INC CDMO 2022-05-25 13:15:03 UTC 0.57 0.25 1000000
AVID BIOSERVICES INC CDMO 2022-05-25 12:45:03 UTC 0.57 0.25 1000000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Prudential Investment Portfolios 12- PGIM QMA Long-Short Equity Fund CDMO -1600.0 shares, $-34512.0 2021-09-30 N-PORT
Advanced Series Trust- AST QMA U.S. Equity Alpha Portfolio CDMO -27000.0 shares, $-582390.0 2021-09-30 N-PORT
AMERICAN BEACON FUNDS- American Beacon SSI Alternative Income Fund CDMO -15383.0 shares, $-448875.94 2021-12-31 N-PORT
THE LAZARD FUNDS, INC.- Lazard Enhanced Opportunities Portfolio CDMO -38938.0 shares, $-1136210.84 2021-12-31 N-PORT
Guidestone Funds- Strategic Alternatives Fund CDMO -7545.0 shares, $-220163.1 2021-12-31 N-PORT
JNL Series Trust- JNL Multi-Manager Alternative Fund CDMO -55470.0 shares, $-1618614.6 2021-12-31 N-PORT
VANGUARD MONTGOMERY FUNDS- VANGUARD MARKET NEUTRAL FUND CDMO -13541.0 shares, $-395126.38 2021-12-31 N-PORT
AQR Funds- AQR Diversified Arbitrage Fund CDMO -80991.0 shares, $-2363317.38 2021-12-31 N-PORT
Morningstar Funds Trust- Morningstar Alternatives Fund CDMO -9796.0 shares, $-184850.52 2022-01-31 N-PORT
Franklin Alternative Strategies Funds- Franklin K2 Alternative Strategies Fund CDMO -33752.0 shares, $-691240.96 2022-02-28 N-PORT

Elevate your investments